Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy
- PMID: 21653724
- PMCID: PMC3154824
- DOI: 10.1152/jn.01123.2010
Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy
Abstract
Diabetes is the most prevalent metabolic disorder in the United States, and between 50% and 70% of diabetic patients suffer from diabetes-induced neuropathy. Yet our current knowledge of the functional changes in sensory nerves and their distal terminals caused by diabetes is limited. Here, we set out to investigate the functional and morphological consequences of diabetes on specific subtypes of cutaneous sensory nerves in mice. Diabetes was induced in C57Bl/6 mice by a single intraperitoneal injection of streptozotocin. After 6-8 wk, mice were characterized for behavioral sensitivity to mechanical and heat stimuli followed by analysis of sensory function using teased nerve fiber recordings and histological assessment of nerve fiber morphology. Diabetes produced severe functional impairment of C-fibers and rapidly adapting Aβ-fibers, leading to behavioral hyposensitivity to both mechanical and heat stimuli. Electron microscopy images showed that diabetic nerves have axoplasm with more concentrated organelles and frequent axon-myelin separations compared with control nerves. These changes were restricted to the distal nerve segments nearing their innervation territory. Furthermore, the relative proportion of Aβ-fibers was reduced in diabetic skin-nerve preparations compared with nondiabetic control mice. These data identify significant deficits in sensory nerve terminal function that are associated with distal fiber loss, morphological damage, and behavioral hyposensitivity in diabetic C57Bl/6 mice. These findings suggest that diabetes damages sensory nerves, leading to functional deficits in sensory signaling that underlie the loss of tactile acuity and pain sensation associated with insensate diabetic neuropathy.
Figures







Similar articles
-
Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.Biol Pharm Bull. 2014;37(5):858-64. doi: 10.1248/bpb.b13-00843. Biol Pharm Bull. 2014. PMID: 24790009
-
Local insulin and the rapid regrowth of diabetic epidermal axons.Neurobiol Dis. 2011 Aug;43(2):414-21. doi: 10.1016/j.nbd.2011.04.012. Epub 2011 Apr 17. Neurobiol Dis. 2011. PMID: 21530660
-
Accelerated diabetic neuropathy in axons without neurofilaments.Brain. 2004 Oct;127(Pt 10):2193-200. doi: 10.1093/brain/awh251. Epub 2004 Aug 2. Brain. 2004. PMID: 15289271
-
The axonopathy of diabetic neuropathy.Diabetes. 1982 Apr;31(4 Pt 1):356-63. doi: 10.2337/diab.31.4.356. Diabetes. 1982. PMID: 6759251 Review. No abstract available.
-
Diabetic neuropathy.Ann Neurol. 1984 Jan;15(1):2-12. doi: 10.1002/ana.410150103. Ann Neurol. 1984. PMID: 6370098 Review.
Cited by
-
Superimposition of hypertension on diabetic peripheral neuropathy affects small unmyelinated sensory nerves in the skin and myelinated tibial and sural nerves in rats with alloxan-induced type 1 diabetes.J Toxicol Pathol. 2020 Jul;33(3):161-169. doi: 10.1293/tox.2020-0003. Epub 2020 Apr 20. J Toxicol Pathol. 2020. PMID: 32764841 Free PMC article.
-
Protective Effects of PACAP in a Rat Model of Diabetic Neuropathy.Int J Mol Sci. 2021 Oct 2;22(19):10691. doi: 10.3390/ijms221910691. Int J Mol Sci. 2021. PMID: 34639032 Free PMC article.
-
Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.Diabetologia. 2019 Jul;62(7):1297-1311. doi: 10.1007/s00125-019-4860-y. Epub 2019 Apr 24. Diabetologia. 2019. PMID: 31016359 Free PMC article.
-
The metabolic syndrome and neuropathy: therapeutic challenges and opportunities.Ann Neurol. 2013 Sep;74(3):397-403. doi: 10.1002/ana.23986. Ann Neurol. 2013. PMID: 23929529 Free PMC article. Review.
-
Bone marrow-derived mesenchymal stem/stromal cells reverse the sensorial diabetic neuropathy via modulation of spinal neuroinflammatory cascades.J Neuroinflammation. 2018 Jun 22;15(1):189. doi: 10.1186/s12974-018-1224-3. J Neuroinflammation. 2018. PMID: 29933760 Free PMC article.
References
-
- Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47: 718–724, 2004 - PubMed
-
- Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55–63, 1994 - PubMed
-
- Chen X, Levine JD. Hyper-responsivity in a subset of C-fiber nociceptors in a model of painful diabetic neuropathy in the rat. Neuroscience 102: 185–192, 2001 - PubMed
-
- Christianson J. Beneficial actions of neurotrophin treatment on diabetes-induced hypoalgesia in mice. Pain 4: 493–504, 2003 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases